Introduction {#s1}
============

Asthma is a chronic inflammatory lung disease characterized by airway hyperresponsiveness (AHR), airway inflammation, excess mucus production and pulmonary remodeling [@pone.0085148-Warrier1]. Arginine metabolism has been found to play a critical role in the pathogenesis of allergic asthma [@pone.0085148-Warrier1], [@pone.0085148-Malerba1] and mounting evidence suggests that nitric oxide (NO) bioavailability plays an important role in the development of allergic inflammation [@pone.0085148-Lara1], [@pone.0085148-Zimmermann1]. Arginine is metabolized by arginase yielding urea and L-ornithine that is further metabolized to polyamines and prolines, which can modulate cell proliferation and collagen production [@pone.0085148-Zimmermann1]. Arginine is also metabolized by nitric oxide synthases (NOS) including neuronal NOS (nNOS), inducible NOS (iNOS) and endothelial NOS (eNOS) [@pone.0085148-Ricciardolo1]. eNOS is expressed in bronchial epithelium and type II alveolar epithelium, nNOS is expressed in airway nervous tissue, and iNOS is expressed in type II alveolar epithelium, lung fibroblasts, airway and vascular smooth muscle cells. The constitutive NO produced by nNOS and eNOS is important for smooth muscle relaxation, bronchodilation and determination of vascular tone and blood pressure while the inducible NO produced by iNOS has pro-inflammatory effects [@pone.0085148-Ricciardolo1].

Asymmetric dimethylarginine (ADMA) is a by-product released from proteolysis of methylated proteins and ADMA competitively inhibits all three NOS by displacing L-arginine from NOS [@pone.0085148-Vallance1]. ADMA also competes with arginine for cellular uptake by cationic amino-acid transporters, affecting the cellular ADMA/arginine ratio [@pone.0085148-Schmidt1], [@pone.0085148-Bogle1]. Analysis of methylarginine metabolism in the cardiovascular system showed that the lung is a major source of ADMA [@pone.0085148-Bulau1]. ADMA has been shown to have profound effects on multiple tissues. Microarray studies showed that pathophysiological concentrations of ADMA elicit significant changes in the gene expression in coronary artery endothelial cells [@pone.0085148-Smith1]. Treatment of primary mouse lung fibroblasts with ADMA induced arginase activity and collagen production [@pone.0085148-Wells1]. ADMA infusion resulted in increased lung resistance and decreased compliance in response to methacholine in mice, which was associated with significantly increased pulmonary collagen deposition [@pone.0085148-Wells1]. ADMA potentiates ovalbumin-induced airway inflammation in a mouse model of asthma [@pone.0085148-Klein1]. In humans, plasma ADMA levels are increased in severe asthma patients compared to nonsevere asthma patients and control subjects [@pone.0085148-Lara1]. Other studies showed that ADMA levels are increased in sputum and exhaled breath condensate from asthma patients [@pone.0085148-Sott1]--[@pone.0085148-Carraro1]. A more recent study showed that lower L-arginine/ADMA ratios are associated with reduced lung function and increased respiratory symptom frequency in subjects with late-onset asthma [@pone.0085148-Holguin1].

DDAH activity is a key determinant of intracellular ADMA concentration [@pone.0085148-Palm1]. Ninety percent of ADMA is metabolized by DDAH and the rest is excreted through the kidneys. DDAH metabolizes ADMA to generate citrulline and dimethylamine. There are two isoforms of DDAH in human, mouse, rat and other species, DDAH1 and DDAH2 [@pone.0085148-Kimoto1]--[@pone.0085148-Tran1]. Immunostaining of human lung tissues showed expression of DDAH1 and DDAH2 in both alveolar and bronchiolar epithelium [@pone.0085148-Pullamsetti1]. One study showed that homozygous DDAH1-deficient mice die before birth while the heterozygous DDAH1-deficient mice have a 20% increased level of ADMA and develop severe endothelial dysfunction [@pone.0085148-Leiper2]. Anther study showed that DDAH1-deficient mice are viable and have significantly increased ADMA levels [@pone.0085148-Hu1]. ADMA levels are decreased in DDAH1-transgenic mice by 50% compared to wild type mice. Further, DDAH1-transgenic mice display a significant increase in NOS activity and a decreased risk of endothelial dysfunction compared to the wild type mice [@pone.0085148-Dayoub1]--[@pone.0085148-Dayoub2]. DDAH1 is the major enzyme responsible for metabolizing ADMA whereas DDAH2 has no detectable role in degrading ADMA *in vivo* [@pone.0085148-Hu1]. In this paper, we determined the role of DDAH1 in the development of AHR and airway inflammation.

Materials and Methods {#s2}
=====================

Mice {#s2a}
----

Mice were maintained and handled under Institutional Animal Care and Use Committee-approved procedures (Cincinnati Children\'s Hospital Medical Center, Protocol Number: 2D10082) and the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Research Council). C57BL/6 wild type and DDAH1-transgenic mice were purchased from Jackson Laboratory (Bar Harbor, ME).

Immunization {#s2b}
------------

C57BL/6 wild type and DDAH1-transgenic mice were immunized with intratracheal instillation of 100 µg of house dust mite (HDM) (*Dermatophagoides pteronyssinus*) extract (Greer Laboratories, Lenoir, NC) in 50 µl of PBS or 50 µl of PBS alone 3 times per week for 3 weeks as previously described [@pone.0085148-Lee1], [@pone.0085148-Brandt1].

Analysis of AHR and airway inflammation {#s2c}
---------------------------------------

Twenty four hours after the last treatment, AHR in response to methacholine (0, 50, 100 and 200 mg/ml) was measured by flexiVent (SCIREQ, Montreal, Canada) as previously described [@pone.0085148-Kramer1]. After AHR measurement, blood, bronchoalveolar lavage (BAL) samples and lung tissues were harvested as previously described [@pone.0085148-Chen1]. The BAL total and differential cell counting as well as histological staining of lung sections by hematoxylin and eosin (H&E) or periodic acid Schiff (PAS) (Thermo Fisher Scientific, Waltham, MA) were performed as described by the manufacturer or described previously [@pone.0085148-Chen1]. ELISAs for total IgE and IgG1 or HDM-specific IgE and IgG1 in BAL fluid (BALF) and serum were done as previously described [@pone.0085148-Sivaprasad1].

RNA-Seq and Bioinformatics Analysis {#s2d}
-----------------------------------

Total RNA was isolated from mouse lungs using Trizol reagent (Invitrogen, Carlsbad, CA), digested with RNase-free DNase and purified using an RNeasy MinElute kit (QIAGEN, Valencia, CA). Equal amounts of RNA were pooled from each mouse lung in an experimental group (n = 4 per group) and analyzed in duplicate. RNA-Seq was performed by the Genomics Sequencing Core in the University of Cincinnati. The RNA-Seq library was constructed using a PrepX SPIA RNA-Seq kit (IntegenX, Pleasanton, CA) and Apollo 324 NGS Library Prep System (IntegenX). 10 ng of total RNA was converted into cDNA suitable for mRNA sequencing. The cDNA was then sheared by Covaris S2 (Covaris, Woburn, MA) under the conditions recommended by IntegenX, followed by Bioanalyzer assay of the size distribution with Agilent High Sensitivity DNA kit (Agilent, Santa Clara, CA). The properly sheared cDNA fragments were purified by Agencourt AMPure XP magnetic beads (Beckman Coulter, Brea CA). Using the IntegenX PrepX ILM DNA library kit for Illumina and Apollo 324 NGS Library Prep System, 500 ng of purified cDNA fragments were then put through end repair, addition of a single 'A' base and ligation of adapters, and indexed individually. The products were purified and enriched by PCR to create the final cDNA library targeting mRNAs. The size of the generated library was validated by Bioanalyzer and the library was quantified using the Kapa Library Quantification kit (Kapa Biosystems, Woburn, MA). Six individually indexed cDNA libraries were equal amount pooled for clustering in cBot system (Illumina, San Diego, CA). Libraries at the concentration of 6.5 pM were clustered onto a flow cell using Illumina\'s TruSeq SR Cluster Kit v3, and sequenced for 50 cycles using the TruSeq SBS kit on Illumina HiSeq system.

Sequence reads were aligned to the reference genome (mm10) using TopHat aligner [@pone.0085148-Trapnell1]. The counts of reads aligning to each gene\'s coding region were summarized using ShortRead and associated Bioconductor packages for manipulating and analysis of next-generation sequencing data and custom-written R programs [@pone.0085148-Morgan1], [@pone.0085148-Ihaka1]. Statistical analysis to identify differentially expressed genes for each comparison was performed using the negative-binomial model of read counts as implemented in the DESeq Biocondoctor package [@pone.0085148-Anders1]. P-values were adjusted for multiple comparisons based on false discovery rates (FDR) [@pone.0085148-Storey1]. Differential expressions with adjusted p-values of \<0.05 were considered statistically significant.

Functional enrichment analysis was performed using the logistic regression based LRpath methodology [@pone.0085148-Sartor1]. The gene lists used in the functional enrichment analysis were from genes associated with Gene Ontology terms and KEGG pathways. The statistical significance of gene list enrichment was determined by the False Discovery Rate cut-off of 0.1. Genes that were both members of at least one statistically significant gene list and had differential expression p-values of \<0.01 were considered to be differentially expressed for the purpose of network analysis. Ingenuity Pathways Analysis (IPA) (Ingenuity Systems, Mountain View, CA) was used to identify integrated and interconnected biological networks and upstream targets for the differentially expressed genes between two groups (with adjusted p-values of \<0.05). RNA-Seq data have been deposited with the NCBI Gene Expression Omnibus (<http://www.ncbi.nlm.nih.gov/geo>) under accession number GSE49047.

RT-PCR {#s2e}
------

Total RNA was isolated from lung tissues using Trizol reagent (Invitrogen), digested with RNase-free DNase and purified using an RNeasy MinElute kit (QIAGEN). Reverse transcription was done using Oligo-dT First-Strand cDNA Synthesis Kit (GE Healthcare, Piscataway, NJ). Quantitative PCR (qPCR) was done using the SYBR Green Master Kit and LightCycler® 480 instrument (Roche Diagnostics, Indianapolis, IN). All primers used are listed in [Table S1](#pone.0085148.s001){ref-type="supplementary-material"}.

Mass Spectrometry (MS) {#s2f}
----------------------

MS was performed by the Analytical & Mass Spectrometry of Small Molecules Core at the University of Cincinnati. The procedure to quantify ADMA was adapted from Schwedhelm *et al* [@pone.0085148-Schwedhelm1]. In brief, BALF and serum samples were filtrated through 0.45 µm filters to remove particles and 200 µl aliquots were then ultra-filtrated through 3 kDa MWCO filters to remove proteins. The samples were derivatized by adding 200 µl of 2 M HCl in 1-butanol for 20 min at 65°C. After evaporation, samples were reconstituted in 200 µl of distilled deionized water and analyzed by nano liquid chromatography chip electrospray ionization ion trap MS (nanoLC-Chip ESI-IT-MS). For nanoLC-Chip ESI-MS/MS analysis, the derivatized ADMA was separated in a microfluidic reverse phase chip column and detected by electrospray ionization with ion trap MS/MS detection. The tandem system consisted of an Agilent 1200 HPLC (Agilent Technologies, Santa Clara, CA), equipped with a capillary and nano pump, used for loading and flushing the on-chip nano column, a chip cube interface that contains the nano-chip column Zorbax SB C-18, 150×0.75 mm (Agilent Technologies), and an Agilent 6300 ion trap XCT system (Agilent Technologies). The mobile phase A consisted of 0.1% formic acid in water while B consisted of 0.1% formic acid in a 7:1 acetonitrile:water solution. A linear gradient from 2% to 25% B was carried out in 10 min and the column was then cleaned with 100% B for 5 min and then regenerated at original conditions for 10 min before the next injection. The flow rate was 0.3 µl per min and the outlet of the column communicates directly with the nano electrospray needle. The analysis was carried out in the MRM mode by following the transition m/z 259.3→214. ADMA standards (Sigma-Aldrich, St. Louis, MO) were derivatized in the same way and quantification was carried out by the external calibration method.

Statistical analysis {#s2g}
--------------------

All values are expressed as mean ± SD. The data were analyzed with a 2-tailed unpaired student\'s t-test with Welch\'s correction or 1-way ANOVA with Newman-Keuls\' post test using Prism 5.0c for Mac OS X from GraphPad Software (San Diego, CA). A p-value of \<0.05 was considered statistically significant.

Results {#s3}
=======

Expression of DDAH1 and DDAH2 is decreased in the lungs and ADMA levels are increased in BALF and serum from HDM-treated mice {#s3a}
-----------------------------------------------------------------------------------------------------------------------------

Since ADMA levels are increased in allergic asthma and DDAH is responsible for the majority of ADMA metabolism, we hypothesized that the increased levels of ADMA are due to decreased expression of DDAH following allergen exposure. We determined the expression of DDAH1 and DDAH2 in the lungs in a mouse model of asthma. C57BL/6 mice were challenged by intratracheal instillation of 100 µg HDM, 3 times per week for 3 weeks. This is a more clinically relevant protocol of chronic allergen exposure with an increased dosage of HDM for the C57BL/6 mouse strain. As shown in [Fig. 1A and 1B](#pone-0085148-g001){ref-type="fig"}, HDM exposure resulted in decreased expression of DDAH1 and DDAH2 in mouse lungs, which correlated with increased levels of ADMA in BALF and serum ([Fig. 1C and 1D](#pone-0085148-g001){ref-type="fig"}).

![Expression of DDAH1 and DDAH2 in lungs and ADMA levels in BALF and serum samples from PBS or HDM-treated C57BL/6 mice.\
The mice were treated with PBS or HDM by 3 intratracheal challenges per week for 3 weeks. (A--B) DDAH1 and DDAH2 expression in lungs (n = 7--9). (C--D) ADMA levels in BALF and serum samples (n = 3). Data are shown as mean±SD. \*, p\<0.05; \*\*, p\<0.01.](pone.0085148.g001){#pone-0085148-g001}

Overexpression of DDAH1 attenuates HDM-induced airway inflammation {#s3b}
------------------------------------------------------------------

We next determined the effect of DDAH overexpression on airway inflammation and AHR in a HDM-induced asthma model using DDAH1-transgenic mice since DDAH1 is the major enzyme responsible for ADMA metabolism [@pone.0085148-Hu1]. The mice were challenged by intratracheal instillation of 100 µg HDM 3 times per week for 3 weeks. Twenty-four hours after the last treatment AHR was measured by flexiVent and airway inflammation was assessed by BAL cell counts. BAL total cell and eosinophil numbers were decreased in HDM-treated DDAH1-transgenic mice compared to HDM-treated wild type mice ([Fig. 2A-2B](#pone-0085148-g002){ref-type="fig"}). No significant differences in inflammatory cell infiltration in airways determined by H&E staining or in mucus production determined by PAS staining of lung sections were observed between HDM-treated DDAH1-transgenic mice and HDM-treated wild type mice (data not shown). No significant difference in AHR was observed in HDM-treated DDAH1-transgenic mice compared to HDM-treated wild type mice (data not shown).

![Airway inflammation in PBS or HDM-treated C57BL/6 wild type and DDAH1-transgenic mice.\
BAL total and differential cell counts in wild type and DDAH1-transgenic mice treated with PBS or HDM (3 intratracheal challenges per week for 3 weeks). WT: wide type; TG: DDAH1-transgenic. Data are shown as mean±SD (n = 5--9). \*, p\<0.05.](pone.0085148.g002){#pone-0085148-g002}

IgE levels in BALF and serum are decreased in DDAH1-transgenic mice compared to wild type mice after HDM treatment {#s3c}
------------------------------------------------------------------------------------------------------------------

We next tested whether allergen sensitization was affected by the overexpression of DDAH1. As shown in [Fig. 3A and 3B](#pone-0085148-g003){ref-type="fig"}, the total IgE levels were decreased in BALF and serum in HDM-treated DDAH1-transgenic mice compared to HDM-treated wild type mice but there was no difference in the levels of total IgG1 in BALF or serum ([Fig. 3C and 3D](#pone-0085148-g003){ref-type="fig"}). The level of HDM-specific IgE was decreased in serum from HDM-treated DDAH1-transgenic mice compared to HDM-treated wild type mice but the level of HDM-specific IgG1 in serum was unaffected ([Fig. 3E and 3F](#pone-0085148-g003){ref-type="fig"}).

![Levels of IgE and IgG1 in BALF and serum in PBS or HDM-treated C57BL/6 wild type and DDAH1-transgenic mice.\
(A) BALF total IgE. (B) Serum total IgE. (C) BALF total IgG1. (D) Serum total IgG1. (E) Serum HDM-specific IgE. (F) Serum HDM-specific IgG1. WT: wide type; TG: DDAH1-transgenic. Data are shown as mean±SD (n = 5--9). \*, p\<0.05.](pone.0085148.g003){#pone-0085148-g003}

Gene expression profiles are significantly different in the lungs of wild type and DDAH1-transgenic mice {#s3d}
--------------------------------------------------------------------------------------------------------

To elucidate the potential mechanisms underlying attenuated HDM-induced airway inflammation in DDAH1-transgenic mice, we determined gene expression profiles in the lungs from C57BL/6 wild type and DDAH1-transgenic mice treated with PBS or HDM (intratracheal instillation of 100 µg of HDM in 50 µl of PBS or 50 µl of PBS alone 3 times per week for 3 weeks) by RNA-Seq.

There were 354 genes differentially expressed in the lungs of PBS-treated wild type and PBS-treated DDAH1-transgenic mice ([Table S2](#pone.0085148.s002){ref-type="supplementary-material"}). The top downregulated genes (with an adjusted p-value of \<0.05) are shown in [Table 1](#pone-0085148-t001){ref-type="table"} (grouped and sorted by fold change), including immune/defense response genes (Rag1, Irg1, Tlr6, etc.), cell structure/adhesion/migration genes (Sprr2a2, Sprr2a1, Adipoq, etc.), cytokine/chemokine genes (Ccl4, Ccl3, Cxcl2 and Il1b), and transcriptional factors (Tcf7 and Stat1). The top upregulated genes (with an adjusted p-value of \<0.05) are shown in [Table 2](#pone-0085148-t002){ref-type="table"} (grouped and sorted by fold change), including muscle/cell structure genes (Myh2, Myh8, Myh4, etc.), ion homeostasis/metabolism genes (Atp2a1, Ckm, Sod1, etc.) and hemopoiesis genes (Hba-a2, Hba-a1, Beta-s, etc.). For the downregulated immune/defense response genes, cytokine/chemokine genes and transcriptional factor genes, IPA analysis showed that the top network was associated with inflammatory response, immunological disease, and respiratory disease ([Fig. 4A](#pone-0085148-g004){ref-type="fig"}). The top network for the upregulated muscle/cell structure genes was associated with organ morphology, skeletal and muscular system development and function, and cancer ([Fig. 4B](#pone-0085148-g004){ref-type="fig"}). The top upstream target for both downregulated and upregulated genes was iNOS (NOS2) ([Fig. 4C](#pone-0085148-g004){ref-type="fig"}).

![Network analysis of differentially expressed genes in the lungs of PBS-treated C57BL/6 wild type and PBS-treated DDAH1-transgenic mice.\
(A) Top network of the downregulated immune/defense response genes, cytokine/chemokine genes and transcriptional factor genes in PBS-treated DDAH1-transgenic mice. (B) Top network of the upregulated muscle/cell structure genes in PBS-treated DDAH1-transgenic mice. (C) Upstream target analysis of genes differentially expressed in PBS-treated wild type and DDAH1-transgenic mice. The genes with an adjusted p-value of \<0.05 were included for analysis.](pone.0085148.g004){#pone-0085148-g004}

10.1371/journal.pone.0085148.t001

###### Genes Downregulated in the Lungs of PBS-treated DDAH1-transgenic Mice versus PBS-treated Wild Type Mice.

![](pone.0085148.t001){#pone-0085148-t001-1}

  Symbol                                                                                           Name                                                         Fold Change
  ----------------------------------------- ------------------------------------------------------------------------------------------------------------------ -------------
  ***Immune/Defense Response***                                                                                                                                
  Rag1                                                                               recombination activating gene 1                                              0.0020
  Irg1                                                                                   immunoresponsive gene 1                                                  0.0042
  Tlr6                                                                                     toll-like receptor 6                                                   0.0224
  Saa3                                                                                      serum amyloid A 3                                                     0.0265
  Clec4e                                                                         C-type lectin domain family 4, member e                                          0.0360
  Ptafr                                                                            platelet-activating factor receptor                                            0.0656
  Pram1                                                                         PML-RAR alpha-regulated adaptor molecule 1                                        0.1024
  Clec4d                                                                         C-type lectin domain family 4, member d                                          0.1306
  Cfd                                                                                 complement factor D (adipsin)                                               0.1491
  Cd4                                                                                          CD4 antigen                                                        0.2667
  Tnfrsf1b                                                                tumor necrosis factor receptor superfamily, member 1b                                   0.3327
  Il1rn                                                                             interleukin 1 receptor antagonist                                             0.3365
  Lilrb3                                                 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3                 0.3596
  Sell                                                                                     selectin, lymphocyte                                                   0.3826
  Acsl1                                                                       acyl-CoA synthetase long-chain family member 1                                      0.4620
  Cybb                                                                              cytochrome b-245, beta polypeptide                                            0.4694
  Lcn2                                                                                         lipocalin 2                                                        0.4804
  Tgtp1                                                                                  T-cell specific GTPase 1                                                 0.4907
  Lilrb4                                                              leukocyte immunoglobulin-like receptor, subfamily B, member 4                               0.4931
  Tgtp2                                                                                  T-cell specific GTPase 2                                                 0.4986
  Csf2rb                                                    colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)                     0.5378
  Ptprc                                                                       protein tyrosine phosphatase, receptor type, C                                      0.6052
  ***Cell Structure/Adhesion/Migration***                                                                                                                      
  Sprr2a2                                                                             small proline-rich protein 2A2                                              0.0179
  Sprr2a1                                                                             small proline-rich protein 2A1                                              0.0179
  Adipoq                                                                     adiponectin, C1Q and collagen domain containing                                      0.0702
  S100a9                                                                     S100 calcium binding protein A9 (calgranulin B)                                      0.0736
  Pla2g7                                                     phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)                     0.1651
  S100a8                                                                     S100 calcium binding protein A8 (calgranulin A)                                      0.2070
  H2-M2                                                                           histocompatibility 2, M region locus 2                                          0.2210
  Sema4d                                     sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D     0.2948
  Itgb2                                                                                      integrin beta 2                                                      0.4746
  Myh6                                                                      myosin, heavy polypeptide 6, cardiac muscle, alpha                                    0.4752
  Itgal                                                                                      integrin alpha L                                                     0.4913
  Actc1                                                                               actin, alpha, cardiac muscle 1                                              0.5662
  Csf3r                                                                     colony stimulating factor 3 receptor (granulocyte)                                    0.5942
  ***Cytokine/Chemokine***                                                                                                                                     
  Ccl4                                                                                chemokine (C-C motif) ligand 4                                              0.0000
  Ccl3                                                                                chemokine (C-C motif) ligand 3                                              0.0114
  Cxcl2                                                                              chemokine (C-X-C motif) ligand 2                                             0.0236
  Il1b                                                                                      interleukin 1 beta                                                    0.1342
  ***Transcriptional Factor***                                                                                                                                 
  Tcf7                                                                           transcription factor 7, T-cell specific                                          0.4134
  Stat1                                                                     signal transducer and activator of transcription 1                                    0.5833
  ***Other***                                                                                                                                                  
  Arpp21                                                                         cyclic AMP-regulated phosphoprotein, 21                                          0.0036
  Gxylt2                                                                              glucoside xylosyltransferase 2                                              0.0112
  1700071M16Rik                                                                         RIKEN cDNA 1700071M16 gene                                                0.0427
  Trim30b                                                                            tripartite motif-containing 30B                                              0.0516
  Cd177                                                                                       CD177 antigen                                                       0.0746
  Niacr1                                                                                    niacin receptor 1                                                     0.0993
  Mmp8                                                                                  matrix metallopeptidase 8                                                 0.1307
  Slfn4                                                                                         schlafen 4                                                        0.1469
  Acpp                                                                                  acid phosphatase, prostate                                                0.2390
  Steap4                                                                                  STEAP family member 4                                                   0.2412
  F13a1                                                                            coagulation factor XIII, A1 subunit                                            0.2631
  Gpnmb                                                                              glycoprotein (transmembrane) nmb                                             0.3398
  Slpi                                                                           secretory leukocyte peptidase inhibitor                                          0.3547
  Bpifa1                                                                          BPI fold containing family A, member 1                                          0.3796
  Gp49a                                                                                     glycoprotein 49 A                                                     0.4032
  Car3                                                                                     carbonic anhydrase 3                                                   0.4062
  Gm1966                                                                                   predicted gene 1966                                                    0.5319
  Ctss                                                                                         cathepsin S                                                        0.6001
  Fth1                                                                                    ferritin heavy chain 1                                                  0.6449

NCBI Gene Expression Omnibus accession numbers GSE49047 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49047>).

10.1371/journal.pone.0085148.t002

###### Genes Upregulated in the Lungs of PBS-treated DDAH1-transgenic Mice versus PBS-treated Wild Type Mice.

![](pone.0085148.t002){#pone-0085148-t002-2}

  Symbol                                                         Name                              Fold Change
  ---------------------------------- ------------------------------------------------------------ -------------
  ***Muscle/Cell Structure***                                                                     
  Myh2                                   myosin, heavy polypeptide 2, skeletal muscle, adult        181.3505
  Myh8                                 myosin, heavy polypeptide 8, skeletal muscle, perinatal      109.1566
  Myh4                                       myosin, heavy polypeptide 4, skeletal muscle            82.8001
  Myh1                                   myosin, heavy polypeptide 1, skeletal muscle, adult         65.6757
  Tnnt3                                              troponin T3, skeletal, fast                     44.0881
  Actn3                                                    actinin alpha 3                           26.0940
  Mylpf                               myosin light chain, phosphorylatable, fast skeletal muscle     14.9051
  Neb                                                          nebulin                               10.4391
  ***Ion Homeostasis/Metabolism***                                                                
  Atp2a1                               ATPase, Ca++ transporting, cardiac muscle, fast twitch 1      45.0004
  Ckm                                                  creatine kinase, muscle                       9.6517
  Sod1                                             superoxide dismutase 1, soluble                   1.8226
  Errfi1                                          ERBB receptor feedback inhibitor 1                 1.7924
  Dpep1                                                 dipeptidase 1 (renal)                        1.6845
  Sgms1                                                sphingomyelin synthase 1                      1.6440
  Glul                                     glutamate-ammonia ligase (glutamine synthetase)           1.4929
  ***Hemopoiesis***                                                                               
  Hba-a2                                           hemoglobin alpha, adult chain 2                   1.6691
  Hba-a1                                           hemoglobin alpha, adult chain 1                   1.6691
  Beta-s                                            hemoglobin subunit beta-1-like                   1.5436
  Hbb-b1                                          hemoglobin, beta adult major chain                 1.5242
  Hbb-b2                                          hemoglobin, beta adult minor chain                 1.5242
  ***MicroRNA***                                                                                  
  Mir5109                                                   microRNA 5109                            2.7839
  ***Other***                                                                                     
  Flrt2                                    fibronectin leucine rich transmembrane protein 2          11.5849
  Gm13375                                                predicted gene 13375                        8.1901
  Gm3893                                                 predicted gene 3893                         5.6492
  Rmrp                                         RNA component of mitochondrial RNAase P               4.8670
  Angptl4                                                angiopoietin-like 4                         2.7019
  Efnb1                                                       ephrin B1                              2.3349
  Zbtb16                                       zinc finger and BTB domain containing 16              2.2658
  Cdkn1a                                      cyclin-dependent kinase inhibitor 1A (P21)             2.2030
  Tsc22d3                                           TSC22 domain family, member 3                    2.1869
  6430548M08Rik                                       RIKEN cDNA 6430548M08 gene                     2.1316
  Krt7                                                        keratin 7                              2.0891
  Bmp6                                               bone morphogenetic protein 6                    1.8952
  Gm10393                                                predicted gene 10393                        1.8802
  Lars2                                         leucyl-tRNA synthetase, mitochondrial                1.8365
  Plxna2                                                      plexin A2                              1.8323
  Eif3e                                 eukaryotic translation initiation factor 3, subunit E        1.7913
  Cpm                                                     carboxypeptidase M                         1.7450
  Rn45S                                                 45S pre-ribosomal RNA                        1.7382
  Vps54                                          vacuolar protein sorting 54 (yeast)                 1.5716
  Dnaja1                                     DnaJ (Hsp40) homolog, subfamily A, member 1             1.5133
  Tmbim6                                    transmembrane BAX inhibitor motif containing 6           1.4524
  Sepp1                                               selenoprotein P, plasma, 1                     1.3714
  Sftpa1                                           surfactant associated protein A1                  1.3527

NCBI Gene Expression Omnibus accession numbers GSE49047 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49047>).

There were 707 genes differentially expressed in the lungs of HDM-treated wild type and HDM-treated DDAH1-transgenic mice ([Table S3](#pone.0085148.s003){ref-type="supplementary-material"}). The top downregulated genes (with an adjusted p-value of \<0.05) are shown in [Table 3](#pone-0085148-t003){ref-type="table"} (grouped and sorted by fold change), including metabolism/transport genes (Fbp1, Dhrs9, Arg1, etc.), immune/defense response genes (Ear11, Chia, Sod3, etc.), cytokine/chemokine genes (Ccl22, Tnfsf12, Ccl9 and Il33), extracellular matrix genes (Col6a2, Muc5ac, Muc4 and Col1a1) and microRNAs (Mir5109 and Mir5107). The top upregulated genes (with an adjusted p-value of \<0.05) are shown in [Table 4](#pone-0085148-t004){ref-type="table"} (grouped and sorted by fold change), including ribosomal complex genes (Rps21, Rps12, Rpl30, etc.) and ribosomal pseudogenes (Gm11968, Gm12191, Gm13253, etc.). The top network for the downregulated immune/defense genes and cytokine/chemokine genes was associated with inflammatory response, cellular movement, and hematological system development and function ([Fig. 5A](#pone-0085148-g005){ref-type="fig"}). The top network for the upregulated ribosomal complex genes and ribosomal pseudogenes is associated with cellular development, cancer, and cellular assembly and organization ([Fig. 5B](#pone-0085148-g005){ref-type="fig"}). The top upstream targets for both downregulated and upregulated genes were IL-13 and FOXA2 ([Fig. 5C](#pone-0085148-g005){ref-type="fig"}).

![Network analysis of differentially expressed genes in the lungs of HDM-treated C57BL/6 wild type and HDM-treated DDAH1-transgenic mice.\
(A) Top network of the downregulated immune/defense response genes and cytokine/chemokine genes in HDM-treated DDAH1-transgenic mice. (B) Top network of the upregulated ribosomal complex genes and ribosomal pseudogenes in HDM-treated DDAH1-transgenic mice. (C) Upstream target analysis of genes differentially expressed in HDM-treated wild type and DDAH1-transgenic mice. The genes with an adjusted p-value of \<0.05 were included for analysis.](pone.0085148.g005){#pone-0085148-g005}

10.1371/journal.pone.0085148.t003

###### Genes Downregulated in the Lungs of HDM-treated DDAH1-transgenic Mice versus HDM-treated Wild Type Mice.

![](pone.0085148.t003){#pone-0085148-t003-3}

  Symbol                                                                                                         Name                                                                       Fold Change
  ------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------- -------------
  ***Metabolism/Transport***                                                                                                                                                               
  Fbp1                                                                                                 fructose bisphosphatase 1                                                              0.1302
  Dhrs9                                                                                      dehydrogenase/reductase (SDR family) member 9                                                    0.1595
  Arg1 [\*](#nt103){ref-type="table-fn"}                                                                    arginase, liver                                                                   0.1808
  Slc26a4                                                                                         solute carrier family 26, member 4                                                          0.2789
  Cox15                                                                              COX15 homolog, cytochrome c oxidase assembly protein (yeast)                                             0.2889
  Chi3l4 [\*](#nt103){ref-type="table-fn"}                                                                chitinase 3-like 4                                                                  0.3373
  Atp1a3                                                                                   ATPase, Na+/K+ transporting, alpha 3 polypeptide                                                   0.3547
  Slc5a1                                                                           solute carrier family 5 (sodium/glucose cotransporter), member 1                                           0.3701
  Clca3                                                                                          chloride channel calcium activated 3                                                         0.3773
  Kcnj15                                                                             potassium inwardly-rectifying channel, subfamily J, member 15                                            0.4207
  Chi3l3 [\*](#nt103){ref-type="table-fn"}                                                                chitinase 3-like 3                                                                  0.4246
  Slco4c1                                                                             solute carrier organic anion transporter family, member 4C1                                             0.4487
  Man2b2                                                                                                mannosidase 2, alpha B2                                                               0.4520
  ***Immune/Defense Response***                                                                                                                                                            
  Ear11                                                                                 eosinophil-associated, ribonuclease A family, member 11                                               0.2201
  Chia [\*](#nt103){ref-type="table-fn"}                                                                   chitinase, acidic                                                                  0.3222
  Sod3                                                                                           superoxide dismutase 3, extracellular                                                        0.3353
  Csf2ra                                                                  colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)                                  0.3959
  Ifitm2                                                                                      interferon induced transmembrane protein 2                                                      0.4031
  Igf1                                                                                               insulin-like growth factor 1                                                             0.4424
  *Osmr*                                                                                                 oncostatin M receptor                                                                0.4612
  ***Cytokine/Chemokine***                                                                                                                                                                 
  Ccl22                                                                                             chemokine (C-C motif) ligand 22                                                           0.2776
  Tnfsf12                                                                                tumor necrosis factor (ligand) superfamily, member 12                                                0.3065
  Ccl9                                                                                              chemokine (C-C motif) ligand 9                                                            0.4578
  Il33 [\*](#nt103){ref-type="table-fn"}                                                                    interleukin 33                                                                    0.4640
  ***Extracellular Matrix***                                                                                                                                                               
  Col6a2                                                                                              collagen, type VI, alpha 2                                                              0.3976
  Muc5ac                                                                                  mucin 5, subtypes A and C, tracheobronchial/gastric                                                 0.4245
  Muc4                                                                                                          mucin 4                                                                       0.4415
  Col1a1                                                                                               collagen, type I, alpha 1                                                              0.4641
  ***Transcriptional Factor***                                                                                                                                                             
  Srebf2                                                                                      sterol regulatory element binding factor 2                                                      0.3294
  Foxp4                                                                                                     forkhead box P4                                                                   0.3743
  Nfic                                                                                                    nuclear factor I/C                                                                  0.4391
  ***MicroRNA***                                                                                                                                                                           
  Mir5109                                                                                                    microRNA 5109                                                                    0.2007
  Mir5107                                                                                                    microRNA 5107                                                                    0.4523
  ***Other***                                                                                                                                                                              
  Syn2                                                                                                        synapsin II                                                                     0.0688
  4833422F24Rik                                                                                       RIKEN cDNA 4833422F24 gene                                                              0.0775
  LOC100048885                                                                                    major urinary protein LOC100048885                                                          0.1392
  Corin                                                                                                          corin                                                                        0.1992
  Zfp366                                                                                                zinc finger protein 366                                                               0.2274
  Zfp385b                                                                                              zinc finger protein 385B                                                               0.2356
  Epha7                                                                                                     Eph receptor A7                                                                   0.2597
  Bahcc1                                                                                        BAH domain and coiled-coil containing 1                                                       0.2673
  Actg2                                                                                         actin, gamma 2, smooth muscle, enteric                                                        0.2694
  Phlda1                                                                                  pleckstrin homology-like domain, family A, member 1                                                 0.2729
  Actc1                                                                                             actin, alpha, cardiac muscle 1                                                            0.2852
  BC048546                                                                                              cDNA sequence BC048546                                                                0.2998
  Trim65                                                                                            tripartite motif-containing 65                                                            0.3015
  Bin2                                                                                                   bridging integrator 2                                                                0.3016
  Fcgbp                                                                                           Fc fragment of IgG binding protein                                                          0.3248
  Prrc2a                                                                                              proline-rich coiled-coil 2A                                                             0.3288
  Dusp8                                                                                             dual specificity phosphatase 8                                                            0.3328
  Rhob                                                                                             ras homolog gene family, member B                                                          0.3346
  Atn1                                                                                                        atrophin 1                                                                      0.3370
  Rpph1                                                                                             ribonuclease P RNA component H1                                                           0.3560
  Midn                                                                                                         midnolin                                                                       0.3735
  Notch3                                                                                           Notch gene homolog 3 (Drosophila)                                                          0.3899
  Sema5a                                      sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A     0.3949
  Gm15401                                                                                                predicted gene 15401                                                                 0.3967
  Tgfb1i1                                                                               transforming growth factor beta 1 induced transcript 1                                                0.4005
  Taok2                                                                                                      TAO kinase 2                                                                     0.4159
  Samd4b                                                                                       sterile alpha motif domain containing 4B                                                       0.4693

Verified by RT-qPCR.

NCBI Gene Expression Omnibus accession numbers GSE49047 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49047>).

10.1371/journal.pone.0085148.t004

###### Genes Upregulated in the Lungs of HDM-treated DDAH1-transgenic Mice versus HDM-treated Wild Type Mice.
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  Symbol                                                                          Name                                             Fold Change
  ------------------------------------ ------------------------------------------------------------------------------------------ -------------
  ***Ribosomal Complex***                                                                                                         
  Rps21                                                                  ribosomal protein S21                                       5.4796
  Rps12                                                                  ribosomal protein S12                                       5.4397
  Rpl30                                                                  ribosomal protein L30                                       4.2587
  Mrps16                                                          mitochondrial ribosomal protein S16                                4.1518
  Rpl34                                                                  ribosomal protein L34                                       3.8427
  Sec61b                                                                   Sec61 beta subunit                                        3.7764
  Rps14                                                                  ribosomal protein S14                                       3.6956
  Rpl36a                                                                 ribosomal protein L36A                                      3.6885
  Rps15a                                                                 ribosomal protein S15A                                      3.6498
  Rpl37a                                                                 ribosomal protein L37a                                      3.6295
  Pttg1                                                           pituitary tumor-transforming gene 1                                3.5963
  Rplp2                                                               ribosomal protein, large P2                                    3.4879
  Rps27                                                                  ribosomal protein S27                                       3.4532
  Rpl27                                                                  ribosomal protein L27                                       3.4067
  Rps28                                                                  ribosomal protein S28                                       3.3511
  Mrpl20                                                          mitochondrial ribosomal protein L20                                3.2634
  ***Ribosomal Pseudogene***                                                                                                      
  Gm11968                                                                  Rps15a pseudogene                                         4.4686
  Gm12191                                                           ribosomal protein L30 pseudogene                                 4.2620
  Gm13253                                                          ribosomal protein S15a pseudogene                                 4.0395
  Rpl34-ps1                                                       ribosomal protein L34, pseudogene 1                                3.8391
  Rplp2-ps1                                                    ribosomal protein, large P2, pseudogene 1                             3.3696
  ***Metabolism/Oxidative Process***                                                                                              
  Qdpr                                                             quinoid dihydropteridine reductase                                5.7248
  Glrx5                                                          glutaredoxin 5 homolog (S. cerevisiae)                              5.0037
  Ndufa2                                                 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2                       4.9044
  Ndufs5                                                     NADH dehydrogenase (ubiquinone) Fe-S protein 5                          4.7132
  Sumf1                                                               sulfatase modifying factor 1                                   4.4089
  Cox7a2l                                                 cytochrome c oxidase subunit VIIa polypeptide 2-like                       4.2862
  Cox17                                           cytochrome c oxidase, subunit XVII assembly protein homolog (yeast)                4.1528
  ***Cytokine/Chemokine***                                                                                                        
  Ccl20                                                             chemokine (C-C motif) ligand 20                                  6.3854
  Cxcl3                                                             chemokine (C-X-C motif) ligand 3                                 3.9814
  ***Other***                                                                                                                     
  Dtwd1                                                                 DTW domain containing 1                                      14.2305
  Flrt2                                                     fibronectin leucine rich transmembrane protein 2                         10.6123
  1110038B12Rik                                                        RIKEN cDNA 1110038B12 gene                                    8.9809
  Scgb3a2                                                          secretoglobin, family 3A, member 2                                7.4584
  Fpr2                                                                 formyl peptide receptor 2                                     6.5479
  Fkbp14                                                                FK506 binding protein 14                                     6.3078
  Hbxip                                                         hepatitis B virus x interacting protein                              4.8871
  BC002163                                                    NADH dehydrogenase Fe-S protein 5 pseudogene                           4.7683
  S100a13                                                           S100 calcium binding protein A13                                 4.6935
  H3f3a                                                                  H3 histone, family 3A                                       4.6727
  Commd1                                                                COMM domain containing 1                                     4.6707
  Osgep                                                            O-sialoglycoprotein endopeptidase                                 4.2386
  2010001M09Rik                                                        RIKEN cDNA 2010001M09 gene                                    4.1526
  Mettl7a2                                                             methyltransferase like 7A2                                    4.1202
  0610007C21Rik                                                        RIKEN cDNA 0610007C21 gene                                    3.9575
  Tmbim4                                                     transmembrane BAX inhibitor motif containing 4                          3.9312
  Snrpe                                                            small nuclear ribonucleoprotein E                                 3.9247
  Plac9                                                                   placenta specific 9                                        3.7440
  Gngt2                                 guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2     3.5724
  Tomm7                                              translocase of outer mitochondrial membrane 7 homolog (yeast)                   3.5352
  Gm9846                                                                  predicted gene 9846                                        3.4544
  Ccdc84                                                            coiled-coil domain containing 84                                 3.4251
  S100a6                                                      S100 calcium binding protein A6 (calcyclin)                            3.3956
  Vamp8                                                          vesicle-associated membrane protein 8                               3.3746
  Shfm1                                                    split hand/foot malformation (ectrodactyly) type 1                        3.3414
  Cd52                                                                        CD52 antigen                                           3.3025
  Mettl7a1                                                             methyltransferase like 7A1                                    3.2925
  Pcolce2                                                        procollagen C-endopeptidase enhancer 2                              3.2669
  Fam166a                                                    family with sequence similarity 166, member A                           3.2667
  Neat1                                              nuclear paraspeckle assembly transcript 1 (non-protein coding)                  3.2657

NCBI Gene Expression Omnibus accession numbers GSE49047 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49047>).

The expression of IL-13, IL-4, IL-33, CCL11, ARG1, MMP-12, CHIA, CHI3L3 and CHI3L4 is decreased in the lungs from DDAH1-transgenic mice compared to wild type mice following allergen challenge {#s3e}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Based on RNA-Seq results, we verified the expression of some key cytokines, chemokines, matrix metallopeptidases and chitinases including IL-13, IL-4, IL-33, CCL11, MMP-12 and CHIA. As shown in [Fig. 6A and 6B](#pone-0085148-g006){ref-type="fig"}, induction of IL-13 and IL-4 expression in the lungs was attenuated in HDM-treated DDAH1-transgenic mice compared to wild type mice. Expression of IL-33 was decreased in lungs from DDAH1-transgenic mice after HDM treatment compared to wild type mice ([Fig. 6C](#pone-0085148-g006){ref-type="fig"}). We found that the expression of CCL11 and MMP-12 was decreased in HDM-treated DDAH1-transgenic mice compared to HDM-treated wild type mice ([Fig. 6D, 6E](#pone-0085148-g006){ref-type="fig"}). The expression of ARG1, a key enzyme in arginine/NO metabolism, was significantly decreased in HDM-treated DDAH1-transgenic mice compared to HDM-treated wild type mice ([Fig. 6F](#pone-0085148-g006){ref-type="fig"}). The difference in expression of iNOS (NOS2) or FOXA2 was not significant between wild type and DDAH1-transgenic mice ([Fig. 6G, 6H](#pone-0085148-g006){ref-type="fig"}). The expression of acidic chitinase (CHIA) and chitinase like proteins (CHI3L3 and CHI3L4) was decreased in the lungs of HDM-treated DDAH1-transgenic mice compared to HDM-treated wild type mice ([Fig. 7A--7C](#pone-0085148-g007){ref-type="fig"}).

![Expression of IL-13, IL-4, IL-33, CCL11, MMP-12, ARG1, NOS2 and FOXA2 in lungs from PBS or HDM-treated C57BL/6 wild type and DDAH1-transgenic mice.\
(A) IL-13. (B) IL-4. (C) IL-33. (D) CCL11 (E) MMP-12. (F) ARG1. (G) NOS2. (H) FOXA2. WT: wide type; TG: DDAH1-transgenic. Data are shown as mean±SD (n = 5-9). \*, p\<0.05; \*\*, p\<0.01; \*\*\*, p\<0.001; ns, not significant.](pone.0085148.g006){#pone-0085148-g006}

![Expression of acidic chitinase (CHIA) and chitinase like proteins (CHI3L3 and CHI3L4) in the lungs of PBS or HDM-treated C57BL/6 wild type and DDAH1-transgenic mice.\
(A) CHIA. (B) CHI3L3. (C) CHI3L4. WT: wide type; TG: DDAH1-transgenic. Data are shown as mean±SD (n = 5--9). \*, p\<0.05; \*\*, p\<0.01.](pone.0085148.g007){#pone-0085148-g007}

Discussion {#s4}
==========

Our data reveal that expression of DDAH1 and DDAH2 is decreased in the lungs in a mouse model of asthma, and overexpression of DDAH1 attenuates allergen-induced airway inflammation. Asthma is a condition of decreased NO bioavailability. ADMA is an endogenous inhibitor of NOS, which is a major source of NO. DDAH1 and DDAH2 are responsible for metabolism of over 90% of ADMA *in vivo*, and our data support a role for DDAH downregulation in asthma pathogenesis.

The mechanism of the observed downregulation of DDAH may be epigenetic modulation. Studies using mouse trophoblast stem cells and trophoblastic tissues of postimplantation mouse embryos showed DNA methylation-dependent epigenetic regulation of DDAH2 gene expression. The CpG island in the DDAH2 promoter was hypermethylated in trophoblast stem cells but hypomethylated in differentiated cells [@pone.0085148-Tomikawa1]. We found that the mouse DDAH1 promoter also contains a CpG island [@pone.0085148-Sujuan1], but their methylation status and relationship to gene expression are unknown. Previous studies have shown that allergen exposure results in altered methylation status of IL-4 and IFNγ promoter CpG islands [@pone.0085148-Kwon1]. It is likely that allergen exposure results in hypermethylation of mouse DDAH1 and DDAH2 promoter CpG islands, which results in decreased expression of DDAH1 and DDAH2 in mouse lungs.

Our data showed that overexpression of DDAH1 attenuated allergen-induced airway inflammation although it had no significant effect on AHR. It is not surprising as studies showed uncoupled airway inflammation and AHR in allergen challenged C57BL/6 mice due to strain-dependent genomic factors [@pone.0085148-Kelada1]. The infiltration of eosinophils into the lungs was decreased in HDM-exposed DDAH1-transgenic mice, which is consistent with the result that expression of CCL11 was decreased in lungs from HDM-treated DDAH1-transgenic mice. The total IgE and HDM-specific IgE levels in BALF or serum were decreased in DDAH1-transgenic mice after HDM exposure, suggesting that overexpression of DDAH1 affected Ig class switch.

The RNA-Seq data showed that overexpression of DDAH1 results in decreased lung expression of multiple immune/defense response genes that are associated with a network of inflammatory responses. The top upstream target is iNOS. A previous study showed that increased ADMA levels increase the expression of iNOS in mouse lungs [@pone.0085148-Klein1], suggesting the effect of DDAH1 overexpression on iNOS expression/activity may be mediated by altered ADMA levels. Following HDM exposure, the expression of ARG1 is significantly decreased in the lungs from DDAH1 transgenic mice, suggesting arginine/NO pathways play important roles in the effect of DDAH1 overexpression on allergic airway inflammation. We found the expression of genes involved in mucus production (Clca3, Muc5ac and Muc4) and collagen synthesis (Col6a2 and Col1a1) is also decreased. Another previous study showed that increased levels of ADMA resulted in increased pulmonary collagen deposition [@pone.0085148-Wells1], suggesting DDAH1 may regulate collagen synthesis through modulation of ADMA levels. Network analysis suggests that DDAH1 regulates mucus production gene expression through IL-13/FOXA2. RT-qPCR data further showed that the expression of IL-13, IL-4 and CCL11 is decreased in HDM-treated DDAH1-transgenic mice, which is consistent with attenuated eosinophil infiltration in airways and decreased serum and BALF IgE levels. Although the difference in expression of iNOS and FOXA2 is not significant between the wild type and DDAH1-transgenic mice, overexpression of DDAH1 may directly or indirectly affect the activity of iNOS and FOXA2. Interestingly, the expression of acidic chitinase (CHIA) and chitinase like proteins (CHI3L3 and CHI3L4) was decreased in the lungs of HDM-treated DDAH1-transgenic mice. Acidic chitinase has been shown to paly important roles in asthma [@pone.0085148-Zhu1]. CHI3L3 and CHI3L4 are rodent specific chitinase like proteins that are induced by Th2 cytokines or allergen challenge and have chemotactic activity [@pone.0085148-Chang1]--[@pone.0085148-Welch1]. Whether acidic chitinase and chitinase like proteins can modulate the expression of DDAH1 requires further studies. Overexpression of DDAH1 may have non-specific effects on gene expression. Generation of cell type specific transgenic mice with different expression levels of the DDAH1-transgene would help minimize the non-specific effects.

In summary, our data suggest that decreased expression of DDAH1 and DDAH2 in lungs may contribute to allergic asthma and overexpression of DDAH1 attenuates allergen-induced airway inflammation through modulation of Th2 responses.
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**Genes differentially expressed in the lungs of PBS-treated wild type and PBS-treated DDAH1-transgenic mice.** For RNA-Seq, equal amounts of RNA were pooled from each mouse lung in an experimental group (n = 4 per group) and analyzed in duplicate. The bioinformatics analyses were described in Materials and Methods. The differentially expressed genes with a p-value of \<0.01 were shown. WT: wild type; TG: DDAH1-transgenic; Inf: infinity.
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**Genes differentially expressed in the lungs of HDM-treated wild type and HDM-treated DDAH1-transgenic mice.** For RNA-Seq, equal amounts of RNA were pooled from each mouse lung in an experimental group (n = 4 per group) and analyzed in duplicate. The bioinformatics analyses were described in Materials and Methods. The differentially expressed genes with a p-value of \<0.01 were shown. WT: wild type; TG: DDAH1-transgenic; Inf: infinity.
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